[Diabetic maculopathy - classification and therapy].
The current clinical classification into focal, diffuse, and ischaemic maculopathy is useful with respect to pathomechanism and therapy. This review discusses the value of standard therapeutical options as well as the recent surgical and pharmacological approaches.
Fauser
Sascha
S
Abteilung für Netzhaut- und Glaskörperchirurgie des Zentrums für Augenheilkunde und Zentrum für Molekulare Medizin, Universität zu Köln.
Krohne
Tim U
TU
Kirchhof
Bernd
B
Joussen
Antonia M
AM
D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D003922:Diabetes Mellitus, Type 1 / Q000145:classification / Q000175:diagnosis / Q000628:therapy; D003930:Diabetic Retinopathy / Q000145:classification / Q000175:diagnosis / Q000628:therapy*; D006801:Humans; D007267:Injections; D017075:Laser Coagulation; D008269:Macular Edema / Q000145:classification / Q000175:diagnosis / Q000628:therapy*; D014222:Triamcinolone Acetonide / Q000008:administration & dosage; D014821:Vitrectomy; D018630:Vitreoretinopathy, Proliferative / Q000628:therapy; D014822:Vitreous Body
D014222:Triamcinolone Acetonide
Die diabetische Makulopathie - Klinik und Therapie.